Skip to main content
Top
Published in: Critical Care 6/2013

Open Access 01-12-2013 | Research

Sustained high serum malondialdehyde levels are associated with severity and mortality in septic patients

Authors: Leonardo Lorente, María M Martín, Pedro Abreu-González, Alberto Domínguez-Rodriguez, Lorenzo Labarta, César Díaz, Jordi Solé-Violán, José Ferreres, Judith Cabrera, Jose Carlos Igeño, Alejandro Jiménez

Published in: Critical Care | Issue 6/2013

Login to get access

Abstract

Introduction

There is a hyperoxidative state in sepsis. The objective of this study was to determine serum malondialdehyde (MDA) levels during the first week of follow up, whether such levels are associated with severity during the first week and whether non-surviving patients showed higher MDA levels than survivors during the first week.

Methods

We performed an observational, prospective, multicenter study in six Spanish Intensive Care Units. Serum levels of MDA were measured in 328 patients (215 survivors and 113 non-survivors) with severe sepsis at days one, four and eight of diagnosis, and in 100 healthy controls. The primary endpoint was 30-day mortality and the secondary endpoint was six -month mortality. The association between continuous variables was carried out using Spearman’s rank correlation coefficient. Cox regression analysis was applied to determine the independent contribution of serum MDA levels on the prediction of 30-day and 6-month mortality. Hazard ratio (HR) and 95% confidence intervals (CI) were calculated as measures of the clinical impact of the predictor variables.

Results

We found higher serum MDA in septic patients at day one (p < 0.001), day four (p < 0.001) and day eight (p < 0.001) of diagnosis than in healthy controls. Serum MDA was lower in surviving than non-surviving septic patients at day one (p < 0.001), day four (p < 0.001) and day eight (p < 0.001). Serum MDA levels were positively correlated with lactic acid and SOFA during the first week. Finally, serum MDA levels were associated with 30-day mortality (HR = 1.05; 95% CI = 1.02-1.09; p = 0.005) and six-month mortality (hazard ratio (HR) = 1.05; 95% CI = 1.02-1.09; p = 0.003) after controlling for lactic acid levels, acute physiology and chronic health evaluation (APACHE)-II, diabetes mellitus, bloodstream infection and chronic renal failure.

Conclusions

To our knowledge, this is the largest series providing data on the oxidative state in septic patients to date. The novel finding is that high serum MDA levels sustained throughout the first week of follow up were associated with severity and mortality in septic patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rocha M, Herance R, Rovira S, Hernández-Mijares A, Victor VM: Mitochondrial dysfunction and antioxidant therapy in sepsis. Infect Disord Drug Targets 2012, 12: 161-178. 10.2174/187152612800100189CrossRefPubMed Rocha M, Herance R, Rovira S, Hernández-Mijares A, Victor VM: Mitochondrial dysfunction and antioxidant therapy in sepsis. Infect Disord Drug Targets 2012, 12: 161-178. 10.2174/187152612800100189CrossRefPubMed
2.
go back to reference Galley HF: Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 2011, 107: 57-64. 10.1093/bja/aer093CrossRefPubMed Galley HF: Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 2011, 107: 57-64. 10.1093/bja/aer093CrossRefPubMed
3.
4.
go back to reference Draper HH, Hadley M: Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990, 186: 421-431.CrossRefPubMed Draper HH, Hadley M: Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990, 186: 421-431.CrossRefPubMed
5.
go back to reference Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A: Biomarkers of oxidative damage in human disease. Clin Chem 2006, 52: 601-623. 10.1373/clinchem.2005.061408CrossRefPubMed Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A: Biomarkers of oxidative damage in human disease. Clin Chem 2006, 52: 601-623. 10.1373/clinchem.2005.061408CrossRefPubMed
6.
go back to reference Ogilvie AC, Groeneveld AB, Straub JP, Thijs LG: Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med 1991, 17: 40-44. 10.1007/BF01708408CrossRefPubMed Ogilvie AC, Groeneveld AB, Straub JP, Thijs LG: Plasma lipid peroxides and antioxidants in human septic shock. Intensive Care Med 1991, 17: 40-44. 10.1007/BF01708408CrossRefPubMed
7.
go back to reference Erdem SS, Yerlikaya FH, Çiçekler H, Gül M: Association between ischemia-modified albumin, homocysteine, vitamin B(12) and folic acid in patients with severe sepsis. Clin Chem Lab Med 2012, 50: 1417-1421.CrossRefPubMed Erdem SS, Yerlikaya FH, Çiçekler H, Gül M: Association between ischemia-modified albumin, homocysteine, vitamin B(12) and folic acid in patients with severe sepsis. Clin Chem Lab Med 2012, 50: 1417-1421.CrossRefPubMed
8.
go back to reference Gelain DP, de Bittencourt Pasquali MA, Comim MC, Grunwald MS, Ritter C, Tomasi CD, Alves SC, Quevedo J, Dal-Pizzol F, Moreira JC: Serum heat shock protein 70 levels, oxidant status, and mortality in sepsis. Shock 2011, 35: 466-470. 10.1097/SHK.0b013e31820fe704CrossRefPubMed Gelain DP, de Bittencourt Pasquali MA, Comim MC, Grunwald MS, Ritter C, Tomasi CD, Alves SC, Quevedo J, Dal-Pizzol F, Moreira JC: Serum heat shock protein 70 levels, oxidant status, and mortality in sepsis. Shock 2011, 35: 466-470. 10.1097/SHK.0b013e31820fe704CrossRefPubMed
9.
go back to reference Andresen M, Regueira T, Bruhn A, Perez D, Strobel P, Dougnac A, Marshall G, Leighton F: Lipoperoxidation and protein oxidative damage exhibit different kinetics during septic shock. Mediators Inflamm 2008, 2008: 168652.PubMedCentralCrossRefPubMed Andresen M, Regueira T, Bruhn A, Perez D, Strobel P, Dougnac A, Marshall G, Leighton F: Lipoperoxidation and protein oxidative damage exhibit different kinetics during septic shock. Mediators Inflamm 2008, 2008: 168652.PubMedCentralCrossRefPubMed
10.
go back to reference Toufekoula C, Papadakis V, Tsaganos T, Routsi C, Orfanos SE, Kotanidou A, Carrer DP, Raftogiannis M, Baziaka F, Giamarellos-Bourboulis EJ: Compartmentalization of lipid peroxidation in sepsis by multidrug-resistant gram-negative bacteria: experimental and clinical evidence. Crit Care 2013, 17: R6. 10.1186/cc11930PubMedCentralCrossRefPubMed Toufekoula C, Papadakis V, Tsaganos T, Routsi C, Orfanos SE, Kotanidou A, Carrer DP, Raftogiannis M, Baziaka F, Giamarellos-Bourboulis EJ: Compartmentalization of lipid peroxidation in sepsis by multidrug-resistant gram-negative bacteria: experimental and clinical evidence. Crit Care 2013, 17: R6. 10.1186/cc11930PubMedCentralCrossRefPubMed
11.
go back to reference Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR: Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995, 23: 646-651. 10.1097/00003246-199504000-00011CrossRefPubMed Goode HF, Cowley HC, Walker BE, Howdle PD, Webster NR: Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction. Crit Care Med 1995, 23: 646-651. 10.1097/00003246-199504000-00011CrossRefPubMed
12.
go back to reference Lorente L, Martín MM, Abreu-González P, Domínguez-Rodríguez A, Labarta L, Díaz C, Solé-Violán J, Ferreres J, Borreguero-León JM, Jiménez A, Morera-Fumero A: Prognostic value of malondialdehyde serum levels in severe sepsis: a multicenter study. PLoS One 2013, 8: e53741. 10.1371/journal.pone.0053741PubMedCentralCrossRefPubMed Lorente L, Martín MM, Abreu-González P, Domínguez-Rodríguez A, Labarta L, Díaz C, Solé-Violán J, Ferreres J, Borreguero-León JM, Jiménez A, Morera-Fumero A: Prognostic value of malondialdehyde serum levels in severe sepsis: a multicenter study. PLoS One 2013, 8: e53741. 10.1371/journal.pone.0053741PubMedCentralCrossRefPubMed
13.
go back to reference Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, International Sepsis Definitions Conference: SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 2001: 530-538.CrossRef Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, International Sepsis Definitions Conference: SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 2001: 530-538.CrossRef
14.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 13: 818-829. 10.1097/00003246-198510000-00009CrossRefPubMed Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985, 13: 818-829. 10.1097/00003246-198510000-00009CrossRefPubMed
15.
go back to reference Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG, for the Working Group on Sepsis-related Problems of the European Society of Intensive Care Medicine: The Sepsis-related Organ Failure Assessment (SOFA) score to describe organ dysfunction/failure. Intensive Care Med 1996, 22: 707-710. 10.1007/BF01709751CrossRefPubMed Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG, for the Working Group on Sepsis-related Problems of the European Society of Intensive Care Medicine: The Sepsis-related Organ Failure Assessment (SOFA) score to describe organ dysfunction/failure. Intensive Care Med 1996, 22: 707-710. 10.1007/BF01709751CrossRefPubMed
16.
go back to reference Kikugawa K, Kojima T, Yamaki S, Kosugi H: Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylediaminotetraacetic acid. Anal Biochem 1992, 202: 249-255. 10.1016/0003-2697(92)90102-DCrossRefPubMed Kikugawa K, Kojima T, Yamaki S, Kosugi H: Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylediaminotetraacetic acid. Anal Biochem 1992, 202: 249-255. 10.1016/0003-2697(92)90102-DCrossRefPubMed
17.
go back to reference Harrell FE: Multivariable modelling strategies. In Regression Modelling Strategies. With Applications to Linear Models, Logistic Regression, and Survival Analysis. Edited by: Harrell FE. New York, NY: Springer-Verlag; 2001:53-85. Harrell FE: Multivariable modelling strategies. In Regression Modelling Strategies. With Applications to Linear Models, Logistic Regression, and Survival Analysis. Edited by: Harrell FE. New York, NY: Springer-Verlag; 2001:53-85.
18.
go back to reference Ware LB, Fessel JP, May AK, Roberts LJ: Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis. Shock 2011, 36: 12-17. 10.1097/SHK.0b013e318217025aPubMedCentralCrossRefPubMed Ware LB, Fessel JP, May AK, Roberts LJ: Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis. Shock 2011, 36: 12-17. 10.1097/SHK.0b013e318217025aPubMedCentralCrossRefPubMed
19.
go back to reference Andrades ME, Ritter C, Dal-Pizzol F: The role of free radicals in sepsis development. Front Biosci (Elite Ed) 2009, 1: 277-287. Andrades ME, Ritter C, Dal-Pizzol F: The role of free radicals in sepsis development. Front Biosci (Elite Ed) 2009, 1: 277-287.
20.
go back to reference Andrades ME, Morina A, Spasić S, Spasojević I: Bench-to-bedside review. Sepsis from the redox point of view. Crit Care 2011, 15: 230. 10.1186/cc10334PubMedCentralCrossRefPubMed Andrades ME, Morina A, Spasić S, Spasojević I: Bench-to-bedside review. Sepsis from the redox point of view. Crit Care 2011, 15: 230. 10.1186/cc10334PubMedCentralCrossRefPubMed
21.
go back to reference Xing HY, Ling YL, Meng AH, Zhao XY, Huang XL: Melatonin improves vascular reactivity of endotoxemia rats. Sheng Li Xue Bao 2005, 57: 367-372.PubMed Xing HY, Ling YL, Meng AH, Zhao XY, Huang XL: Melatonin improves vascular reactivity of endotoxemia rats. Sheng Li Xue Bao 2005, 57: 367-372.PubMed
22.
go back to reference Sener G, Toklu H, Kapucu C, Ercan F, Erkanli G, Kaçmaz A, Tilki M, Yeğen BC: Melatonin protects against oxidative organ injury in a rat model of sepsis. Surg Today 2005, 35: 52-59.CrossRefPubMed Sener G, Toklu H, Kapucu C, Ercan F, Erkanli G, Kaçmaz A, Tilki M, Yeğen BC: Melatonin protects against oxidative organ injury in a rat model of sepsis. Surg Today 2005, 35: 52-59.CrossRefPubMed
23.
go back to reference Paskaloğlu K, Sener G, Kapucu C, Ayanoğlu-Dülger G: Melatonin treatment protects against sepsis-induced functional and biochemical changes in rat ileum and urinary bladder. Life Sci 2004, 74: 1093-1104. 10.1016/j.lfs.2003.07.038CrossRefPubMed Paskaloğlu K, Sener G, Kapucu C, Ayanoğlu-Dülger G: Melatonin treatment protects against sepsis-induced functional and biochemical changes in rat ileum and urinary bladder. Life Sci 2004, 74: 1093-1104. 10.1016/j.lfs.2003.07.038CrossRefPubMed
24.
go back to reference Fulia F, Gitto E, Cuzzocrea S, Reiter RJ, Dugo L, Gitto P, Barberi S, Cordaro S, Barberi I: Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001, 31: 343-349. 10.1034/j.1600-079X.2001.310409.xCrossRefPubMed Fulia F, Gitto E, Cuzzocrea S, Reiter RJ, Dugo L, Gitto P, Barberi S, Cordaro S, Barberi I: Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001, 31: 343-349. 10.1034/j.1600-079X.2001.310409.xCrossRefPubMed
25.
go back to reference Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, Cordaro S, Corona G, Trimarchi G, Barberi I: Effects of melatonin treatment in septic newborns. Pediatr Res 2001, 50: 756-760. 10.1203/00006450-200112000-00021CrossRefPubMed Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, Cordaro S, Corona G, Trimarchi G, Barberi I: Effects of melatonin treatment in septic newborns. Pediatr Res 2001, 50: 756-760. 10.1203/00006450-200112000-00021CrossRefPubMed
26.
go back to reference Sahib AS, Al-Jawad FH, Alkaisy AA: Effect of antioxidants on the incidence of wound infection in burn patients. Ann Burns Fire Disasters 2010, 23: 199-205.PubMedCentralPubMed Sahib AS, Al-Jawad FH, Alkaisy AA: Effect of antioxidants on the incidence of wound infection in burn patients. Ann Burns Fire Disasters 2010, 23: 199-205.PubMedCentralPubMed
27.
go back to reference Srinivasan V, Pandi-Perumal SR, Spence DW, Kato H, Cardinali DP: Melatonin in septic shock: some recent concepts. J Crit Care 2010, 25: e1-e6.CrossRefPubMed Srinivasan V, Pandi-Perumal SR, Spence DW, Kato H, Cardinali DP: Melatonin in septic shock: some recent concepts. J Crit Care 2010, 25: e1-e6.CrossRefPubMed
28.
go back to reference Bourne RS, Mills GH: Melatonin: possible implications for the postoperative and critically ill patient. Intensive Care Med 2006, 32: 371-379. 10.1007/s00134-005-0061-xCrossRefPubMed Bourne RS, Mills GH: Melatonin: possible implications for the postoperative and critically ill patient. Intensive Care Med 2006, 32: 371-379. 10.1007/s00134-005-0061-xCrossRefPubMed
29.
go back to reference Escames G, Acuña-Castroviejo D, López LC, Tan DX, Maldonado MD, Sánchez-Hidalgo M, León J, Reiter RJ: Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J Pharm Pharmacol 2006, 58: 1153-1165. 10.1211/jpp.58.9.0001CrossRefPubMed Escames G, Acuña-Castroviejo D, López LC, Tan DX, Maldonado MD, Sánchez-Hidalgo M, León J, Reiter RJ: Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence. J Pharm Pharmacol 2006, 58: 1153-1165. 10.1211/jpp.58.9.0001CrossRefPubMed
30.
go back to reference Rinaldi S, Landucci F, De Gaudio AR: Antioxidant therapy in critically septic patients. Curr Drug Targets 2009, 10: 872-880. 10.2174/138945009789108774CrossRefPubMed Rinaldi S, Landucci F, De Gaudio AR: Antioxidant therapy in critically septic patients. Curr Drug Targets 2009, 10: 872-880. 10.2174/138945009789108774CrossRefPubMed
31.
go back to reference Srinivasan V, Mohamed M, Kato H: Melatonin in bacterial and viral infections with focus on sepsis: a review. Recent Pat Endocr Metab Immune Drug Discov 2012, 6: 30-39. 10.2174/187221412799015317CrossRefPubMed Srinivasan V, Mohamed M, Kato H: Melatonin in bacterial and viral infections with focus on sepsis: a review. Recent Pat Endocr Metab Immune Drug Discov 2012, 6: 30-39. 10.2174/187221412799015317CrossRefPubMed
Metadata
Title
Sustained high serum malondialdehyde levels are associated with severity and mortality in septic patients
Authors
Leonardo Lorente
María M Martín
Pedro Abreu-González
Alberto Domínguez-Rodriguez
Lorenzo Labarta
César Díaz
Jordi Solé-Violán
José Ferreres
Judith Cabrera
Jose Carlos Igeño
Alejandro Jiménez
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2013
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc13155

Other articles of this Issue 6/2013

Critical Care 6/2013 Go to the issue